Going public without an underwritten offering: who it actually fits, how the mechanics differ, and the parts of the work, nearly all of it, that stay exactly as hard as an IPO.
We tell you honestly whether the path fits, then build the identical readiness an opening auction forgives even less than a roadshow.
Direct listing advisory: candidate fit, price formation, and listing standards
Key takeaways
What it is. Going public without an underwritten offering: the candidate screen, how the price forms in an opening auction instead of a bookbuild, the registration statement without an offering, and day-one float without a lockup.
Where it breaks. A direct listing changes how the price forms and who sells, but the S-1, the PCAOB audit, and the readiness bar are identical to an IPO's, and the exchange listing standards have tightened to close the microcap resale route.
How we help. We run the four-question candidate screen with numbers, supply the inputs price formation depends on, and carry the identical readiness work whichever path the board chooses.
A direct listing removes the offering, not the work. The registration statement is real, the PCAOB audit is real, the readiness bar is identical, and the reporting life that starts on day one is the same as any IPO’s. What disappears is the underwritten machinery: the bookbuild, the lockup convention, the offering-price negotiation, replaced by an opening auction and a set of dynamics that suit a specific and honestly narrow profile of company.
This page covers the direct-listing-specific layer. The path comparison against IPOs and SPACs sits on going public advisory, the readiness framework on IPO readiness, and the document build on S-1 preparation; here is what changes when there is no offering underneath the S-1.
Candidate fit
Who a direct listing actually fits: the four-question screen
Direct listings are invoked far more often than executed. The honest screen is four questions, and a real candidate answers yes to all four. Do investors already know you? Without a bookbuild, day-one demand comes from existing awareness: strong consumer or developer brands, well-covered late-stage names, crossover investors already on the cap table. Do you need primary capital? The classic direct listing raises none, so if the balance sheet needs funding the case weakens fast (the primary variant exists, with its own frictions). Does your shareholder base want the exit? No lockup and immediate float serve employee and early-investor liquidity, a feature for them and a volatility source for you. Can you price yourself? There is no underwriter discovery, so the reference price builds from your own private-market data. Clear all four and you are a genuine candidate; clear two and you are an IPO candidate attracted by the lower fees.
The candidate screen, run with numbers rather than preferences. Illustrative.
Price formation
How the price forms without a bookbuild
Without an underwritten offering there is no bookbuild, so the price forms in public and finance feeds every layer. Private-market data, recent secondary trades and primary rounds, is the raw material for the reference price. The exchange sets the reference price, informed by that private trading and the financial advisors’ input; it is not an offering price. The investor day substitutes for the roadshow, and because Regulation FD and the disclosure rules apply in full, its financial content is held to the S-1 standard and KPI definitions are locked before they are spoken. The opening auction, run by the designated market maker, discovers the opening price, with none of the stabilization an underwritten deal provides. The company’s contribution is a disclosure record coherent enough that the price forming in public forms on real numbers, plus a flash close and preliminary ranges if a fiscal quarter closes mid-process.
Price formation in a direct listing under the exchange auction rules. Illustrative.
Exchange standards
Listing standards and the microcap resale route
A public listing has to clear the exchange’s distribution standards: round-lot holders (300 on the Nasdaq Capital Market, 400 on the Nasdaq Global Market and NYSE, with at least half holding $2,500 or more of unrestricted stock), about 1.1 million publicly held shares held by non-affiliates, and a minimum market value of publicly held shares ($15 million under the net-income standard). The microcap route exploited a gap: a secondary (resale) direct listing registers existing holders’ shares and raises no capital, so issuers once met the market-value threshold with selling-shareholder shares and a reference price while assembling the minimum round-lot holders, producing a listing with no real offering or genuine float. Nasdaq has closed the gap in stages: from April 2025, the market-value threshold must be met from shares sold in the IPO, excluding selling-shareholder shares; from December 2025, a $15 million minimum market value of unrestricted publicly held shares under the net-income standard; and in 2026, heightened standards for China-based issuers, a $25 million minimum raise and no direct listing on the Capital Market (Global Select only), with faster delisting below $5 million.
Nasdaq and NYSE initial listing standards, current as of 2026 and evolving. Illustrative.
The microcap screen
The new reality for microcaps
After the 2025 and 2026 rule changes, the low-cost resale route is effectively closed for microcaps, and the screen comes down to three questions. Capital source: are you raising $15 to $25 million in a bona fide offering, or relying on resale shares that no longer count toward the market-value threshold (April 2025)? Geography: a China, Hong Kong, or Macau base triggers Nasdaq Rule 5210(l), which requires a $25 million firm-commitment IPO and bars those issuers from Capital and Global Market direct listings. Distribution quality: can you source 300 to 400 independent round-lot holders, at least half holding $2,500 or more, now that inflated holder counts no longer qualify? For most microcaps, the remaining path onto a national exchange is a bona fide underwritten offering, not a direct listing.
The microcap screen after the 2025 to 2026 rule changes. Illustrative.
This is for you if
The board is weighing a direct listing and wants the fit assessed by someone not selling the path.
Shareholders want liquidity more than the company needs capital, and the mechanics need pricing.
Aggressive pre-listing equity grants are creating a 409A gap nobody has modeled to a reference price.
The listing date is set and the day-one equity, withholding, and reporting mechanics are unrehearsed.
What you get
The candidate screen Four questions answered with numbers, and the primary-variant risk priced against an IPO.
The registration content F-pages, MD&A, and the complete tie-out record the litigation backdrop makes non-optional.
Price-formation inputs The private trading record, investor-day content, and flash-close capability, assembled and rehearsed.
Day-one mechanics The 409A bridge to the reference range, and the equity settlement and withholding plumbing tested before the open.
How We Help
What we deliver
On a direct listing engagement, you get the honest fit answer, then the full readiness behind it.
The candidate screenFour questions answered with numbers, and the primary-variant risk priced against an IPO.
The registration contentF-pages, MD&A, and the complete tie-out record the litigation backdrop makes non-optional.
Price-formation inputsThe private trading record, investor-day content, and flash-close capability, assembled and rehearsed.
Day-one mechanicsThe 409A bridge to the reference range, and the equity settlement and withholding plumbing tested before the open.
When companies bring us in
The board is weighing a direct listing and wants the fit assessed by someone not selling the path.
Shareholders want liquidity more than the company needs capital, and the mechanics need pricing.
Aggressive pre-listing equity grants are creating a 409A gap nobody has modeled to a reference price.
The listing date is set and the day-one equity, withholding, and reporting mechanics are unrehearsed.
Our Experience
Where we have done this work
Engagement Notes
The path decision, run with numbers
Direct-listing evaluations inside broader path advisory: the four-question candidate screen run against real shareholder bases and capital needs, primary-variant execution risk priced against traditional IPO certainty, and, in most cases, the honest recommendation that the profile fit a different path, delivered before fees were spent on the wrong one.
Engagement Notes
Readiness that transfers across paths
Because the readiness bar is identical, our going-public work transfers: PCAOB uplifts, position memos, 409A bridges, and flash-close capability built for companies that kept the direct-listing option open while preparing, with the same package serving whichever path the board ultimately chose.
The Detail
The gaps, and how we close each one
Issue 01
Who a direct listing actually fitsCandidate Fit
Direct listings get invoked far more often than executed, usually by companies attracted to lower fees and no dilution who lack the two things the path quietly requires: demand that exists without a roadshow manufacturing it, and shareholders who want liquidity more than the company needs capital.
The treatment
The honest screen has four questions. Do investors already know you? Without a bookbuild, day-one demand comes from existing awareness: strong consumer or developer brands, heavily covered late-stage names, crossover investors already in the cap table. Do you need primary capital? The classic direct listing raises none; if the balance sheet needs funding, the case weakens fast (the primary variant exists, next section, with its own frictions). Does your shareholder base want the exit? The mechanism serves employee and early-investor liquidity, no lockup, immediate float, which is a feature for them and a volatility source for you. Can you price yourself? There is no underwriter discovery; the reference price builds from your own data. Companies that clear all four are genuine candidates; companies that clear two are IPO candidates attracted by the lower fees. We run this screen as part of the path decision, with numbers rather than preferences.
What we do: We run the four-question candidate screen with numbers, and tell you plainly when the profile fits a different door.
Issue 02
Secondary versus primary direct listings: the differencesMechanics
The direct listings people remember were secondary: existing holders selling, no company proceeds. Exchange rules now permit primary direct listings, the company selling shares into the opening auction, but the variant carries constraints that explain why it remains rare.
The treatment
In a secondary direct listing, the company registers existing holders’ shares for resale, receives no proceeds, and the float forms from whoever chooses to sell at the opening; the company’s work is the registration statement, the disclosure, and the reference-price support. A primary direct listing adds a company capital raise executed inside the opening auction under exchange rules: the shares must sell in that auction within the disclosed price range, which concentrates execution risk into a single trade in a way a bookbuilt IPO spreads across a roadshow. The accounting and disclosure consequences are modest but real: use-of-proceeds and capitalization sections return, dilution math returns, and the offering-expense accounting follows equity-issuance treatment. Most candidates who truly need primary capital end up comparing the primary direct listing against a traditional IPO and choosing the IPO’s certainty; we run that comparison with the execution risk priced in, beyond the fees.
What we do: We price the primary variant's auction execution risk against an underwritten raise before the structure is chosen.
Issue 03
Exchange listing standards and the microcap crackdownListing Standards
The resale direct listing was for years the low-cost route microcaps used to reach a national exchange: register existing holders’ shares for resale, raise no new capital, and satisfy the exchange’s market-value requirement with those shares. A multi-year sequence of Nasdaq and SEC rule changes has closed that route, which is why the candidate screen above now matters more for smaller issuers than it once did.
The treatment
The distribution standards. A national-exchange listing requires a minimum number of round-lot holders (holders of 100 shares or more), 300 on the Nasdaq Capital Market and 400 on the Nasdaq Global Market and the NYSE, and at least half of them must each hold $2,500 or more of unrestricted stock. That value floor is designed to stop issuers from inflating holder counts by distributing single shares to shell accounts. A listing also needs a minimum market value of unrestricted publicly held shares and a minimum public float.
April 2025: the resale shares stop counting. Effective April 11, 2025, Nasdaq requires the market-value threshold to be met solely through shares sold in a bona fide public offering, excluding shares registered only for resale; Nasdaq had found that issuers meeting the threshold with resale shares showed higher listing-day volatility (Cozen O’Connor).
December 2025: the net-income float rises. The SEC approved an increase in the minimum market value of unrestricted publicly held shares under the net-income standard from $5 million to $15 million, effective January 2026. That standard had let smaller profitable companies list with a lower float; the change standardizes the liquidity thresholds across entry paths (Dechert).
2026: the Capital Market and China dead-ends. Companies are now precluded from using a direct listing to debut on the Nasdaq Capital Market, the tier historically used by smaller issuers. Under Nasdaq Rule 5210(l), approved in May 2026, issuers primarily operating in China, Hong Kong, or Macau must conduct a firm-commitment underwritten IPO raising at least $25 million and may not direct-list on the Global or Capital markets; their only direct-listing path is the Nasdaq Global Select Market, whose thresholds are out of reach for a microcap (K&L Gates).
What it means. For a microcap, the entry question is no longer a high enough stock price. It is the capital source (raising $15 to $25 million in new cash, or relying on insider paper that no longer counts), the geography (a China, Hong Kong, or Macau base triggers the $25 million firm-commitment floor), and the distribution quality (300 or more independent holders, at least half at $2,500 or more). For most microcaps, a bona fide underwritten offering, not a resale direct listing, is the remaining path.
Weighing a direct listing? Talk to us before the fee comparison decides what the fit analysis should.
The registration statement without an offeringS-1 Variant
The direct listing S-1 is structurally familiar, with different offering-related sections: no underwriting section, a plan of distribution describing an auction, financial advisors who are deliberately not underwriters, and a litigation backdrop, share traceability, that shapes how counsel and accountants approach the document.
The treatment
The document carries everything an IPO S-1 carries, F-pages to registrant standard, MD&A with quantified drivers, the full tie-out discipline, with the offering scaffolding swapped out: the plan of distribution describes the opening auction mechanics rather than an underwriting syndicate, registered shares are the existing holders’ (plus any primary tranche), and the financial advisors engaged for the process sit outside underwriter status by design, which also means the comfort-letter and circle-up machinery of an underwritten deal largely does not apply; the discipline survives anyway because we run the tie-out standard for the company’s own protection. That protection matters: direct listings sit downstream of Section 11 traceability litigation, where registered and unregistered shares hit the market simultaneously, a legal landscape counsel owns, but one whose practical instruction to finance is total disclosure hygiene, because the document is the defense.
What we do: We build the registration statement's financial content to the full tie-out standard the litigation backdrop demands.
Issue 05
The reference price and the opening auction: finance's inputsPrice Formation
Without a bookbuild, the price forms in public: the exchange sets a reference price informed by private-market trading and advisor input, an investor day substitutes for the roadshow, and the opening auction discovers the rest. Finance feeds every layer of that process.
The treatment
Our work here is supplying the inputs that price formation depends on: a clean record of private secondary trading and recent primary rounds (the reference price’s raw material), the investor-day financial content held to the same standard as the S-1 because Regulation FD and the disclosure rules apply to it in full, KPI definitions locked before they are spoken to the market, and, where a fiscal quarter closes inside the process, the flash close and preliminary ranges exactly as in an IPO. The auction itself belongs to the exchange and the designated market maker; the company’s contribution is a disclosure record coherent enough that the price forming in public is forming on real numbers. Investors remember the day-one price, not the preparation behind it; the preparation still has to happen.
What we do: We assemble the private-trading record, investor-day content, and flash-close capability the price formation depends on.
Issue 06
Readiness: the same requirements, plus heavier 409A scrutinyReadiness
Every readiness requirement of an IPO applies unchanged: PCAOB audits, positions, controls, the close. One area sharpens: with no underwriter-negotiated price, the gap between recent 409A valuations and the day-one trading price is exposed with unusual clarity.
The treatment
Run the full readiness framework without discount: the audit uplift on the same clock, position memos to the same standard, and a close process that can support quarterly reporting from the first day of trading. The direct-listing-specific edge is cheap stock in reverse: an IPO’s offering price is negotiated and the grant-date bridge explains the climb to it; a direct listing’s day-one price is discovered, and a large gap over recent 409A values invites the same staff scrutiny with less narrative cover. The answer is the same discipline, sharpened: contemporaneous valuations through the pre-listing period, PWERM methodologies that reflect the approaching listing honestly, and the grant-by-grant bridge (per our capital markets treatment) built to the reference price range rather than an offering price. Companies granting equity aggressively in the final private year should model this exposure before the grants, not after the print.
What we do: We run the identical readiness framework, with the 409A bridge built to the reference range before the grants, not after the print.
Issue 07
Day one and after: float without a lockupDay One & After
No lockup means the entire eligible base can sell immediately: employee equity converts to a live tax and administration event on day one, the float is whatever holders decide it is, and the reporting clock starts identically to an IPO’s, with none of the stabilization an underwritten deal provides.
The treatment
Prepare the day-one mechanics as a project: employee equity administration at scale, RSU settlements, sell-to-cover tax withholding executed into a live market, option exercise waves, with the payroll, treasury, and broker plumbing rehearsed before the open, and the stock-compensation accounting consequences, including any liquidity-triggered vesting, quantified in advance exactly as for an IPO double trigger. Investor relations starts without the underwriter aftermarket apparatus, so the guidance and KPI policy decided pre-listing carries more weight, and the first 10-Q lands on the standard clock regardless of how trading opened. From the reporting side, a direct listing and an IPO are indistinguishable by week three, which is the practical argument for building the reporting machine to the same standard whichever path you take.
What we do: We rehearse the day-one equity mechanics, settlements, withholding, vesting charges, before the market opens on them.
FAQ
Frequently asked questions
Is a direct listing cheaper than an IPO?
The underwriting discount goes away; the audit, legal, readiness, and advisor costs do not, and financial advisors in a direct listing are paid real fees. The savings are meaningful but smaller than the headline, and they buy you execution risk an underwriter would otherwise carry.
Can we raise money in a direct listing now?
Yes, primary direct listings are permitted under exchange rules, with the raise executed inside the opening auction within a disclosed range. The concentration of execution risk into that single auction is why most companies needing capital still choose the underwritten path.
Do we still need PCAOB audits and full readiness?
Entirely. The registration statement, audit standard, controls expectations, and reporting obligations are identical to an IPO's. A direct listing changes how the price forms and who sells, nothing about what the company must be able to produce.
What happens to our 409A valuations in a direct listing?
They meet the day-one price with no negotiated offering price in between, so a large gap draws scrutiny with less cover. Contemporaneous valuations through the pre-listing period and a grant-by-grant bridge to the reference range are the protection, built before the print.
Why is there no lockup, and should we impose one?
No underwriters means no one to require it; the open float is the mechanism's point. Companies can adopt contractual or structured release arrangements, and some have, but doing so trades away the liquidity story that justified the path. It is a board decision we model, not a default.
Sources & authorities
Primary sources for this page
Primary direct listings.SEC statement on primary direct listings (December 2020): capital raised in the opening auction without a traditional underwritten offering.
Exchange listing standards.Nasdaq Initial Listing Guide: round-lot holders, publicly held shares, and market-value thresholds.
Initial listing liquidity.Nasdaq’s April 11, 2025 rule: the market value of publicly held shares must come from offering shares, not resale shares.
China-based issuers.Nasdaq Rule 5210(l) (SEC-approved May 2026): a $25 million firm-commitment IPO, and direct listing only on the Global Select Market.
Selective disclosure.Regulation FD: applies in full to the investor day that substitutes for the roadshow.
Registration-statement liability.Securities Act Section 11: the traceability backdrop that makes disclosure hygiene the defense.
Stock compensation and cheap stock. ASC 718: the 409A bridge to the reference-price range, exposed with less cover when the price is discovered.
This page summarizes SEC rules and staff guidance for general information, and is not accounting or legal advice. Rules change; confirm the current text before you rely on it.